**Core Concept**
Aldosterone antagonists, also known as mineralocorticoid receptor antagonists, are a class of medications that block the action of aldosterone, a hormone produced by the adrenal glands that plays a crucial role in regulating electrolyte balance and blood pressure. By blocking aldosterone, these medications can help reduce blood pressure and alleviate symptoms of heart failure.

**Why the Correct Answer is Right**
The mechanism of action of aldosterone antagonists involves binding to the mineralocorticoid receptor (MR), which is activated by aldosterone. This binding inhibits the transcription of genes involved in sodium retention and potassium excretion in the kidneys, leading to a decrease in blood pressure. However, aldosterone antagonists are not useful in the treatment of certain conditions, particularly those where their diuretic effects may be counterproductive.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because aldosterone antagonists can be useful in the treatment of primary aldosteronism, a condition where excess aldosterone production leads to hypertension and hypokalemia. By blocking aldosterone, these medications can help reduce blood pressure and alleviate symptoms.

**Option B:** This option is incorrect because aldosterone antagonists can be useful in the treatment of heart failure, particularly in patients with NYHA class III-IV symptoms. By reducing blood pressure and fluid overload, these medications can help improve symptoms and reduce morbidity.

**Option C:** This option is incorrect because aldosterone antagonists can be useful in the treatment of resistant hypertension, a condition where blood pressure remains elevated despite treatment with multiple antihypertensive medications. By blocking aldosterone, these medications can help reduce blood pressure and improve outcomes.

**Clinical Pearl / High-Yield Fact**
One important consideration when using aldosterone antagonists is their potential to cause hyperkalemia, particularly in patients with renal impairment. It is essential to monitor potassium levels closely in these patients and adjust the dose or discontinue the medication if necessary.

**Correct Answer:** D.